Description:
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY
GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Chromosome Abnormalities |
Class |
X Chromosome Markers |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization after cell line submission to CCR
|
ISCN
|
46,XY,inv(9)(p11q13),add(11)(q25)[7]/46,XY,inv(9)(p11q13)[13]
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
3 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis and by Chromosome Analysis |
|
Gene |
G6PD |
Chromosomal Location |
Xq28 |
Allelic Variant 1 |
305900.0010; G6PD SEATTLE-LIKE |
Identified Mutation |
ASP282HIS; G6PD Seattle-like, which produces a relatively mild phenotype, has a substitution of histidine for aspartic acid at amino acid 282, resulting from a GAT-to CAT change in exon 8. The G-to-C transition is at nucleotide 844. |
Remarks |
46,XY,inv(9); G6PD(Seattle), Xg(a) antigen positive; Sardinian; 24% of cells have marker chromosome 11q+ at passage 5; G6PD mutation is 844G>C (Asp282His {D282H}) |
Xu, W., Westwood, B., Bartsocas, C.S., Malcorra-Azpiazu, J.J., Indrak, K., and Beutler, E., Glucose-6 Phosphate Dehydrogenase Mutations and Haplotypes in Various Ethnic Groups Blood85(1):257-263 1995 |
PubMed ID: 7803800 |
|
Siniscalco M, Filippi G, Latte B, Piomelli S, Rattazzi M, Gavin J, Sanger R, Race RR, Failure to detect linkage between Xg and other X-borne loci in Sardinians. Ann Hum Genet29:231-52 1966 |
PubMed ID: 5297079 |
Passage Frozen |
3 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|